Oct 19, 2017 ... A California state court jury handed a major win to Johnson & Johnson Thursday, determining that the company is not responsible for a woman's cancer that she claims she developed from inhaling asbestos fibers in popular talc-based hygiene products. The lawsuit filed by plaintiff Tina Herford and her ...
Dec 14, 2017 ... Status: Distribution checks have been mailed. Exclusion Deadline: Thursday, October 24, 2013. Objection Deadline: Thursday, October 24, 2013. Settlement Hearing: Thursday, November 14, 2013. Claims Filing Deadline: Tuesday, December 24, 2013. Files: Order Approving Distribution of Net Settlement ...
vs. ) the City of St. Louis. ) JOHNSON & JOHNSON, et al.,. ) Honorable Rex M. Burlison. ) Defendants/Appellants. ) Filed: October 17, 2017. OPINION. Johnson & Johnson appeals the trial court's judgment after a jury verdict in favor of the estate of Jacqueline Fox in this product liability suit. We reverse and vacate the.
Oct 17, 2017 ... Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they ... FILE PHOTO: Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York October 15, 2015. ... The case is Estate of Jacqueline Fox et al v.
Berg v. Johnson & Johnson et al, No. 4:2009cv04179 - Document 330 (D.S.D. 2013) case opinion from the District of South Dakota US Federal District Court.
Gumm et al v. Molinaroli et al. Assigned to: Judge Pamela Pepper. Cause: 15: 78m(a) Securities Exchange Act. Date Filed: 08/16/2016. Jury Demand: Plaintiff. Nature of Suit: 850. Securities/Commodities. Jurisdiction: Federal Question. Plaintiff. Arlene D Gumm represented by Gregg M Fishbein. Lockridge Grindal Nauen ...
Feb 13, 2017 ... Lauren Fishbein, Ignaty Leshchiner, Vonn Walter, Ludmila Danilova, A. Gordon Robertson, Amy R. Johnson, Tara M. Lichtenberg, Bradley A. Murray, Hans K. Ghayee, Tobias Else, ... In this issue of Cancer Cell, Fishbein et al. report novel driver genes, pathogenic mechanisms, and markers of malignancy.